These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 122813)

  • 1. Hepatitis B surface antigen and its subtypes in an institution for the mentally retarded.
    Perry E; Chaudhary RK; Cleary TE; Roughley FR
    Can Med Assoc J; 1975 Jan; 112(1):46-8. PubMed ID: 122813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of hepatitis B infection among residents of an institution for the mentally retarded.
    Chaudhary RK; Perry E; Cleary TE
    Am J Epidemiol; 1977 Feb; 105(2):123-6. PubMed ID: 138362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody to hepatitis B antigen (Australia antigen) among residents of a Finnish institution for the mentally retarded.
    Tevaluoto-Aarnio M; Werner B; London WT
    Med Biol; 1975 Feb; 53(1):51-9. PubMed ID: 124806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hepatitis B at an open institution for the mentally retarded. Immunogenic effect of a recombinant anti-hepatitis-B vaccine].
    García O; Bruguera M; Mayor A; Sánchez-Tapias JM; Vall O; Rodés J
    Enferm Infecc Microbiol Clin; 1990 Mar; 8(3):148-52. PubMed ID: 2151250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A longitudinal study of hepatitis infection in an institution for the mentally retarded.
    Williamson HG; Lehmann NI; Dimitrakakis M; Sharma DL; Gust ID
    Aust N Z J Med; 1982 Feb; 12(1):30-4. PubMed ID: 6952837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Predisposition of Down syndrome to chronic infection with the hepatitis B virus].
    Rua Armesto MJ; Ramírez Marín V; Onaindia Ercoreca MT; García Aguado J; Ruiz Moreno M
    An Esp Pediatr; 1993 Jun; 38(6):529-31. PubMed ID: 8368682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis-B surface antigen and antibody: prevalence and persistence in institutionalized and noninstitutionalized persons.
    McMillan BC; Hanson RP; Golubjatnikov R; Sinha SK
    Public Health Rep; 1979 Jun; 94(3):262-7. PubMed ID: 156381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis A and B in non-institutionalized mentally retarded patients.
    Renner F; Andrle M; Horak W; Rett A
    Hepatogastroenterology; 1985 Aug; 32(4):175-7. PubMed ID: 2932380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of serological markers, hepatitis B virus DNA and elevated serum amino transferase values in institutionalized mentally handicapped males and females: an epidemiological study of HBV infection in residents with Down's syndrome or other forms of mental deficiency.
    van Ditzhuijsen TJ; Kleijnen FM; Rijntjes PJ; van Loon AM; Yap SH
    Eur J Epidemiol; 1988 Sep; 4(3):349-56. PubMed ID: 2972557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus infection among mentally retarded patients in institutions, Okinawa, Japan.
    Hayashi J; Kashiwagi S; Noguchi A; Nakashima K; Ikematsu H; Kajiyama W; Nomura H
    Fukuoka Igaku Zasshi; 1989 Sep; 80(9):436-40. PubMed ID: 2807128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus infection in an institution for the mentally retarded.
    van Ditzhuijsen TJ; de Witte-van der Schoot E; van Loon AM; Rijntjes PJ; Yap SH
    Am J Epidemiol; 1988 Sep; 128(3):629-38. PubMed ID: 2970793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis and Down's syndrome.
    Madden DL; Matthew EB; Dietzman DE; Purcell RH; Sever JL; Rostafinski M; Mata A
    Am J Ment Defic; 1976 Jan; 80(4):401-6. PubMed ID: 129005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of HBeAg and anti-HBe in an institution for the mentally retarded.
    Gust ID; Dimitrakakis M; Sharma DL
    Aust N Z J Med; 1978 Oct; 8(5):471-3. PubMed ID: 154317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of hepatitis B markers in Indochinese refugees.
    Chaudhary RK; Nicholls ES; Kennedy DA
    Can Med Assoc J; 1981 Dec; 125(11):1243-6. PubMed ID: 7332883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Markers of hepatitis B infection in Tari District, Southern Highlands Province, Papua New Guinea.
    Sanders RC; Lewis D; Dyke T; Alpers MP
    P N G Med J; 1992 Sep; 35(3):197-201. PubMed ID: 1296422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and significance of hepatitis B surface antigen in a general hospital.
    Feinman SV; Krassnitzky O; Sinclair JC; Wrobel DM; Berris B
    Can Med Assoc J; 1975 Jan; 112(1):43-5. PubMed ID: 1109723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of markers of hepatitis B virus infection in various countries: a WHO collaborative study.
    Sobĕslavský O
    Bull World Health Organ; 1980; 58(4):621-8. PubMed ID: 6969134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of hepatitis associated antigen (HAA) in an institution for the mentally retarded.
    Chance ER
    Am J Ment Defic; 1972 Jul; 77(1):1-5. PubMed ID: 4262234
    [No Abstract]   [Full Text] [Related]  

  • 19. Study on the control of hepatitis B virus infection in an institution for the mentally retarded.
    Broggini M; Maggiolo F; Bianchi E; Torre D
    Boll Ist Sieroter Milan; 1983; 62(6):495-500. PubMed ID: 6234005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis-B surface antigen among residents of an institution for the mentally retarded.
    Bruhl HH; Bauer H; Levy BS; Siem RA
    Minn Med; 1976 Apr; 59(4):263-7. PubMed ID: 131906
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.